India · Delayed Price · Currency is INR Nephro Care India Statistics
Total Valuation
NSE:NEPHROCARE has a market cap or net worth of INR 1.20 billion. The enterprise value is 1.06 billion.
| Market Cap | 1.20B |
| Enterprise Value | 1.06B |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:NEPHROCARE has 16.49 million shares outstanding. The number of shares has increased by 24.16% in one year.
| Current Share Class | 16.49M |
| Shares Outstanding | 16.49M |
| Shares Change (YoY) | +24.16% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 65.71% |
| Owned by Institutions (%) | 5.95% |
| Float | 5.65M |
Valuation Ratios
The trailing PE ratio is 45.01.
| PE Ratio | 45.01 |
| Forward PE | n/a |
| PS Ratio | 1.57 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 34.20 |
| EV / Sales | 1.39 |
| EV / EBITDA | 14.08 |
| EV / EBIT | 31.66 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 28.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 5.87% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.28M |
| Profits Per Employee | 92,558 |
| Employee Count | 334 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:NEPHROCARE has paid 11.61 million in taxes.
| Income Tax | 11.61M |
| Effective Tax Rate | 27.30% |
Stock Price Statistics
The stock price has decreased by -50.65% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -50.65% |
| 50-Day Moving Average | 97.95 |
| 200-Day Moving Average | 127.87 |
| Relative Strength Index (RSI) | 35.44 |
| Average Volume (20 Days) | 67,180 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NEPHROCARE had revenue of INR 761.59 million and earned 30.91 million in profits. Earnings per share was 1.61.
| Revenue | 761.59M |
| Gross Profit | 406.88M |
| Operating Income | 33.40M |
| Pretax Income | 42.53M |
| Net Income | 30.91M |
| EBITDA | 75.11M |
| EBIT | 33.40M |
| Earnings Per Share (EPS) | 1.61 |
Balance Sheet
The company has 140.51 million in cash and n/a in debt, with a net cash position of 140.51 million or 8.52 per share.
| Cash & Cash Equivalents | 140.51M |
| Total Debt | n/a |
| Net Cash | 140.51M |
| Net Cash Per Share | 8.52 |
| Equity (Book Value) | 554.28M |
| Book Value Per Share | 33.65 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 53.42%, with operating and profit margins of 4.39% and 4.06%.
| Gross Margin | 53.42% |
| Operating Margin | 4.39% |
| Pretax Margin | 5.58% |
| Profit Margin | 4.06% |
| EBITDA Margin | 9.86% |
| EBIT Margin | 4.39% |
| FCF Margin | n/a |
Dividends & Yields
NSE:NEPHROCARE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.16% |
| Shareholder Yield | -24.16% |
| Earnings Yield | 2.58% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |